Patients and Caregivers Say Goodbye to Weight Scales and ER Visits

BELLEVUE, WA / ACCESS Newswire / July 17, 2025 / BodiGuide Inc. today announced the development of a Continuous Fluid Monitoring System that, for the first time, allows heart failure patients, along with their doctors and caregivers, to continuously monitor and evaluate fluid retention before hospitalization is required.

BodiGuide

The BodiGuide System includes the first wearable device specifically designed to replace weight scales and pitting edema tests in the management of heart failure. This new patented system continuously measures ankle circumference and eliminates problems caused by unreliable or ineffective methods of monitoring heart failure patients.

An Industry in Crisis

Heart failure patients and their care providers face special challenges because they must continuously monitor fluid retention and make medication adjustments before disease progression requires hospitalization. These requirements have never been adequately met, which explains why heart failure hospitalization is the largest contributor to Medicare spending on an annual basis.

What was once a growing pain point in the healthcare industry has rapidly become a crisis in the management of chronic diseases. Heart failure is currently estimated to affect six million people and is expected to impact eight million by 2030 -- more than 26 million people worldwide have been identified as heart failure patients.

BodiGuide's Continuous Fluid Monitoring System meets the healthcare industry's urgent need for a more reliable and effortless method of measuring fluid retention in heart failure patients. Especially notable is its ability to eliminate the need for patients to follow daily procedures or abide by burdensome routines.

Current Systems Inadequate

Current methods of managing heart failure rely on surrogate measurements, such as body weight, to identify fluid retention. Conventional systems often require the patient to perform an unnatural task on a daily basis. These systems do not provide a direct measure of fluid status, and they rely on patient adherence, which is both inconvenient and unreliable. As a consequence, the process of managing heart failure is often inadequate for preventing disease progression, which leads to hospitalization.

Fluid retention that goes undetected often leads to hospital visits where the body's fluid balance is adjusted to reduce excess fluid buildup, also known as congestion. The BodiGuide Continuous Fluid Monitoring System was specifically designed to address these problems. It offers direct measurement of fluid retention, which may allow medications to be adjusted before hospitalization becomes necessary.

Heart failure specialists need a reliable way to monitor the efficacy of prescribed treatments, and BodiGuide's quantification of fluid retention is the most direct method of achieving that goal.

A Company Founded on MedTech and Heart Failure Expertise

Created by medical device veterans with a decade of experience as caregivers for heart failure patients, the BodiGuide approach is based on real-world experience that shows only 14% of patients are able to weigh themselves every day or routinely engage with an unfamiliar device.

BodiGuide's wearable device operates with the simplicity of an automatic tape measure. Employing a tension-free strap, waterproof design, and a long-life battery, patients effortlessly gain immediate and continuous visibility of the fluid build-up in their ankles, without requiring special procedures or daily routines.

The BodiGuide team is comprised of a rare combination of heart failure expertise, medical device commercialization experience, and startup success in highly-regulated industries. Together, they bring more than 50 years of combined experience at market-leading organizations such as Boston Scientific, Medtronic, Siemens, and Spacelabs.

Accurate in Any Setting or Location

BodiGuide's anklet uses proprietary sensors and calibration techniques to achieve exceptional accuracy. It prevents patient activity from distorting measurement data, providing both accuracy and repeatability in any setting or location. At the same time, the device automatically locates the optimal position for measuring fluid on the patient's ankle, ensuring reliability.

Continuous monitoring alleviates the patient's reliance on doctor visits, checkups or other methods that only provide a snapshot of data or fragmented information. The continuous measurement and recognition of fluid retention enables patient-care techniques that empower both the patient and healthcare professionals.

New Capabilities in Heart Failure Management

The BodiGuide Anklet is a wearable biosensor that continuously quantifies fluid retention by measuring ankle circumference. By quantifying interstitial fluid volume-the most important clinical biomarker of cardiac decompensation-the anklet provides critical information that healthcare professionals have never had access to before.

BodiGuide's anklet provides patients and clinicians with unique capabilities across the spectrum of heart failure management. From baseline modeling to data acquisition, activity compensation to trend identification, the device's error-free reporting offers a new approach to managing heart failure as a chronic disease.

About BodiGuide

BodiGuide was established with the simple goal of keeping heart failure patients out of the hospital. The company's proprietary biosensor enables the continuous monitoring of fluid retention, providing patients and healthcare professionals with the data they need to address a crisis in the healthcare industry.

Media Contact:
Company: BodiGuide
Website:https://bodiguide.com/
Email: info@bodiguide.com
Address: Bellevue, WA

SOURCE: BodiGuide